Myeloproliferative Neoplastic Diseases Observatory From Brest
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Brest
About this trial
All patients diagnosed or followed in Brest University Hospital for Philadelphia negative myeloproliferative neoplasms will be included in this observational study.
Myeloproliferative neoplasms recorded included: polycythemia vera, essential Thrombocythemia and Primary Myelofibrosis.
This is a not interventional study. Alive patients need to sign a non-opposition consent form.
Patients will be followed until last news (death, change of reference centre...).
Eligibility criteria
Qualifiers
Patients with essentiel thrombocythemia, polycythemia vera or primary myelofibrosis
Signature of the non-opposition consent form
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1CHRU de Brest29609, Brest France
Sponsors and collaborators
University Hospital, Brest
Lead sponsor
Source ClinicalTrials.gov